In this study, the authors not only did not observe any increased risk of CI-AKI with SGLT2-i usage after PCI but also observed an unadjusted ORs of CI-AKI KDIGO 54% lower in the SGLT2-i user group compared with the non-user group [0.46 (95% CI: 0.276–0.75); p = 0.02]. Here, SLC5A2 is linked to acute kidney injury.